Cargando…
Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review
Cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies target the underlying cause of cystic fibrosis (CF), and are generally well-tolerated; however, real-world studies indicate the frequency of discontinuation and adverse events (AEs) may be higher than what was observed in...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795777/ https://www.ncbi.nlm.nih.gov/pubmed/33374882 http://dx.doi.org/10.3390/jcm10010023 |